Medical Cannabis Evidence-Based Care: Endocannabinoid System Clinical Research and Cannabinoid Clinical Trials
Clinical Takeaway People experiencing a first episode of psychosis have measurable rates of criminal legal involvement both before and after entering treatment, with specific individual factors predicting who is at greatest risk. Early identification of…
Cannabis use patterns in first episode psychosis and schizophrenia: A scoping review and case series.
Cannabis use is associated with psychosis development and symptom relapse in persons with schizophrenia spectrum disorders (SCZ). As U.S. states legalize can...
Endocannabinoid System Research: First-Episode Psychosis
First-episode psychosis predictors include substance use and aggressive behavior, which are linked to criminal legal involvement. Understanding these predictors helps clinicians implement early interventions. The endocannabinoid system research supports…
Endocannabinoid System in First-Episode Psychosis Care
People with first-episode psychosis have elevated rates of criminal legal involvement that are measurable at baseline and predictable using identifiable clinical and demographic factors. Early identification of individuals at higher risk for legal…
Endocannabinoid System Research and Clinical Psychosis Care
Clinical psychosis care benefits from understanding the endocannabinoid system's role in first-episode psychosis. Research highlights predictors of legal involvement during early psychosis. This knowledge aids targeted interventions to improve patient…
Endocannabinoid System & Psychosis Risk: Clinical Evidence
Clinical evidence highlights the role of the endocannabinoid system psychosis risk in first episode psychosis. Identifying risk factors early can improve treatment outcomes. This research supports coordinated care to reduce legal system involvement.
Research Digest: 4 Recent Studies – April 09, 2026
This research digest presents 4 recent cannabis research studies curated for clinical relevance and evidence quality. Each study offers insights into cannabis effects, safety, and psychiatric associations. Stay informed with this April 2026 update on…
Cannabis Use Patterns in First Episode Psychosis and Schizophrenia: A Scoping Review and Case Series
Cannabis use patterns schizophrenia are critical to understanding psychosis and schizophrenia development. This review highlights inconsistent measurement methods in current research. Better assessment tools are needed for clinical practice in this…